Form 4: IN8BIO Director Acquires Stock Options

Director Peter C. Brandt acquired stock options for 49,490 shares of IN8BIO, Inc. at an exercise price of $0.24 on December 19, 2024.

Summary

• On December 19, 2024, Peter C. Brandt, a director of IN8BIO, Inc., acquired stock options for 49,490 shares.
• The exercise price for these options is $0.24 per share.
• The options vest on December 19, 2025, contingent upon Brandt's continued service to the company.
• The options expire on December 19, 2034.

Sentiment

Score: 6

Explanation: The sentiment is neutral. It's a routine disclosure of stock option grants to a director, which can be seen as a positive sign of alignment but doesn't necessarily indicate a major shift in the company's prospects.

Positives

• The acquisition of stock options by a director can be seen as a positive sign, indicating confidence in the company's future performance.

Industry Context

Form 4 filings are routine disclosures required by the SEC to ensure transparency in insider trading activities. This filing indicates changes in beneficial ownership by a company insider.

Stakeholder Impact

• The granting of stock options to a director aligns their interests with those of the shareholders, potentially incentivizing them to work towards increasing shareholder value.

Key Dates